Stockscreener 앱 받기
75.50
17.59%
-16.12
시간 외 거래:
77.01
1.51
+2.00%
전일 마감가:
$91.62
열려 있는:
$81.38
하루 거래량:
78.21M
Relative Volume:
6.95
시가총액:
$111.97B
수익:
$19.35B
순이익/손실:
$2.78B
주가수익비율:
40.38
EPS:
1.8696
순현금흐름:
$3.82B
1주 성능:
-19.50%
1개월 성능:
-20.28%
6개월 성능:
-29.30%
1년 성능:
-27.08%
1일 변동 폭
$75.00
$81.78
1주일 범위
$75.00
$94.25
52주 변동 폭
$75.00
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
75.50 | 135.87B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
108.20 | 189.57B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
360.66 | 137.99B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
101.84 | 132.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
79.77 | 47.64B | 5.88B | 1.34B | 799.60M | 2.3489 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific Corporation net sales up 15.9% to USD 5.286B in Q4 2025 - Medical Buyer
Boston Scientific’s Earnings Call Highlights Durable Growth - TipRanks
Stifel lowers Boston Scientific stock price target to $110 on EP results - Investing.com India
Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors - The Motley Fool
Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors - The Motley Fool
Boston Scientific (BSX) Exceeds Q4 2025 Financial Targets - GuruFocus
These stocks are today’s movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and more - MSN
Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell - TechStock²
U.S. Markets Ended Wednesday Mixed As Super Micro Computer Led, Boston Scientific Lagged - Barron's
Boston Scientific stock price target lowered to $110 at BTIG on PFA concerns - Investing.com India
Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX - TechStock²
AMD, AbbVie, Boston Scientific, Eli Lilly, MP, Super Micro, Palantir, and More Movers - Barron's
Why Boston Scientific stock plummeted today - MSN
BTIG Cuts Boston Scientific Price Target to $110 From $132, Buy Rating Maintained - marketscreener.com
Boston Scientific Corp (BSX) Q4 2025 Earnings Call Highlights: Surpassing Financial Goals with Robust Growth - GuruFocus
Boston Scientific shares fall as key segment's performance spooks investors - marketscreener.com
Boston Scientific shares tumble on weak 2026 outlook - Investing.com
Boston Scientific slides after quarterly sales of key products disappoint - TradingView
Boston Scientific Still Has a Moat, but Slower PFA Growth Leads to Lower Fair Value Estimate - Morningstar
Why Boston Scientific Stock Plummeted Today - AOL.com
Boston Scientific continues to see electrophysiology success despite slowdown in growth - MedTech Dive
Why Boston Scientific (BSX) Shares Are Getting Obliterated Today - Yahoo Finance
BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat - TradingView
Boston Scientific, AbbVie Beat Quarterly Views; Shares Slump Amid Weakness in Certain Segments - 富途牛牛
Piper Sandler Adjusts Price Target on Boston Scientific to $105 From $120, Maintains Overweight Rating - marketscreener.com
Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short - MassDevice
Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat - marketscreener.com
What Spooked Investors In Boston Scientific’s 2026 Outlook? - Stocktwits
Boston Scientific Earnings Beat Estimates. It’s the Worst Stock in the S&P 500 Today. - Barron's
Boston Scientific shares slide on cautious 2026 revenue forecast - marketscreener.com
Boston Scientific sees Q1 adjusted EPS 78c-80c, consensus 80c - TipRanks
BSX Earnings: Boston Scientific Stock (BSX) Plunges 17% on Weak Guidance - TipRanks
Earnings call transcript: Boston Scientific beats Q4 2025 EPS, stock falls - Investing.com India
Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results - TipRanks
Boston Scientific stock hits 52-week low at 81.38 USD - Investing.com
Boston Scientific stock hits 52-week low at 81.38 USD By Investing.com - Investing.com Canada
Boston Scientific profit, sales rise but issues soft guidance - MSN
Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance Singapore
Boston Scientific Faces Market Turbulence Post Penumbra Acquisition Announcement - timothysykes.com
Boston Scientific (BSX) Shares Drop Following Q4 Results and FY2 - GuruFocus
Boston Scientific (BSX) Shares Drop Despite Beating Q4 2025 Esti - GuruFocus
Boston Scientific tops Q4 forecasts, shares slip modestly - MSN
Boston Scientific Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Boston Scientific reports Q4 adjusted EPS 80c, consensus 78c - TipRanks
Boston Scientific stock falls as electrophysiology division misses targets - Investing.com
Boston Scientific (NYSE:BSX) Reports Q4 CY2025 In Line With Expectations - Finviz
Boston Scientific Stock Slips On A Slower 2026 Outlook - Finimize
Boston Scientific to Acquire Valencia Technologies and Expand Bladder Care Portfolio - The Healthcare Technology Report.
Interested in our Q4 2025 earnings? - www.bostonscientific.com
Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
S&P 500 Futures Up in Premarket Trading; Mercury Systems, Boston Scientific Lag - Barron's
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
4.89%
자본화:
|
볼륨(24시간):